Skip to content
OpenCapital
Get started

Envoy Medical COCH EBITDA

EBITDA at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
$3.99M+156%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K—
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%—
Debt / equity0.1×—
Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

−$6.0Mebit+
$73.0KDepreciation Depletion & Amortization
=-$5.89M

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's EBITDA?
Envoy Medical (COCH) reported EBITDA of -$5.89M in Q1 2026.
How has Envoy Medical's EBITDA changed year-over-year?
Envoy Medical's EBITDA decreased by 16.6% year-over-year, from -$5.05M to -$5.89M.
What is the long-term trend for Envoy Medical's EBITDA?
Over 2 years (2023 to 2025), Envoy Medical's EBITDA has grown at a 9.8% compound annual growth rate (CAGR), from -$18.23M to -$21.97M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.